![Ella Korets-Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ella Korets-Smith
Corporate Officer/Principal presso ANTIBE THERAPEUTICS INC.
Profilo
Ms. Ella Korets-Smith is a Chief Strategy Officer at Virica Biotech, Inc. and a Vice President-Business Development at Antibe Therapeutics, Inc. Ms. Korets-Smith was previously employed as a Director-Business Development by IMV, Inc., a Vice President-Business Development by Advanced Proteome Therapeutics Corp., a Global Brand Manager by Nordion (Canada), Inc., and a Chief Executive Officer & Director by ToHealth Ltd.
She received her graduate degree from the University of Toronto and an MBA from Dalhousie University.
Posizioni attive di Ella Korets-Smith
Società | Posizione | Inizio |
---|---|---|
ANTIBE THERAPEUTICS INC. | Corporate Officer/Principal | - |
Virica Biotech, Inc.
![]() Virica Biotech, Inc. Pharmaceuticals: MajorHealth Technology Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018. | Fondatore | 01/01/2018 |
Precedenti posizioni note di Ella Korets-Smith
Società | Posizione | Fine |
---|---|---|
ToHealth Ltd.
![]() ToHealth Ltd. Medical/Nursing ServicesHealth Services ToHealth Ltd. provides health and wellbeing services. The private company is based in London, UK. The CEO of the British company is Robin Skinner. | Amministratore Delegato | - |
NORDION INC | Corporate Officer/Principal | - |
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
IMV INC. | Corporate Officer/Principal | - |
Formazione di Ella Korets-Smith
University of Toronto | Graduate Degree |
Dalhousie University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
IMV INC. | Health Technology |
ANTIBE THERAPEUTICS INC. | Health Technology |
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
Aziende private | 3 |
---|---|
Nordion (Canada), Inc.
![]() Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
ToHealth Ltd.
![]() ToHealth Ltd. Medical/Nursing ServicesHealth Services ToHealth Ltd. provides health and wellbeing services. The private company is based in London, UK. The CEO of the British company is Robin Skinner. | Health Services |
Virica Biotech, Inc.
![]() Virica Biotech, Inc. Pharmaceuticals: MajorHealth Technology Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018. | Health Technology |
- Borsa valori
- Insiders
- Ella Korets-Smith